INVO Bioscience, Inc. (IVOB.OB) – Positive Data Results Support Worldwide Marketing Expansion
INVO Bioscience Inc., a medical device company focused on treatment options for patients diagnosed with infertility, today announced that Dr. Elkin Lucena of the Columbian Fertility and Sterility Center’s (CECOLFES LTDA) in Columbia recently presented the results of 95 fertility treatment cycles involving INFO Bioscience’s INVOcell process. Results were presented at the 66th Annual Meeting of the American Society of Reproductive Medicine (ASRM) in Denver. INVOcell is INVO Bioscience’s leading medical device, used in infertility treatment that enables egg fertilization and early embryo development in the woman's vaginal cavity. The results of CECOLFES’s study demonstrated clinical pregnancy rates of 43…